2-Methylbenzo[d]isothiazol-3(2H)-one 1,1-dioxide, 95.0%, 5g

(6-Methyl-1,2,4,5-tetrazin-3-yl)methanamine hydrochloride, 250mg

trans-4-(Aminomethyl)cyclohexanecarboxylic acid, 98.0%, 100g

N-methoxy-N-methyl-2-(pyridin-4-ylsulfanyl)acetamide, 95.0%, 2g

Cuvette d'échantillon Type 2116, 1000 ml, 4 pièce(s)

Tubes à centrifuger coniques, sans bord, 50 ml, Stérile, 300 Pièce(s)

1-(4-Bromo-3-methylphenyl)-2,2,2-trifluoroethanol, 95%, 1g

2-[(4-{[(tert-butoxy)carbonyl]amino}butyl)amino]pyridine-3-carboxylic acid, 95.0%, 10g

Ethyl-(1-methyl-piperidin-4-yl)-amine, 95.0%, 5g

1-METHYL-4-AZEPANOL HCL, 97.0%, 1g

2-(dibutylamino)-1-{2,7-dichloro-9-[(4-chlorophenyl)methylidene]-9H-fluoren-4-yl}ethan-1-ol, 95.0%, 25g

[(Aminocarbonyl)amino]acetic acid, 97.0%, 500g

4-Bromo-3-fluorobenzenesulfonyl chloride, 97.0%, 25g